Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

T1-IFN

Financiado

Cerrado

Definition and characterization of type I interferonopathies

Although the concept of grouping Mendelian disorders associated with an up-regulation of type I interferon (IFN) has not been previously recognised in the medical literature, my past and current work argues that this concept has s... ver más

31/10/2018

UEDIN

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2018-10-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UEDIN

0.00€ | Lider

INSERM

N.D. | Participante

UNIVERSITY OF MANCHESTER

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

E-T1IFNs Elaboration of the type I interferonopathies 2M€ Cerrado

MitoFeron Mitochondrial integrity and autoinflammation 185K€ Cerrado

PID2021-125106OB-C31 VARIANTES POST-CIGOTICAS RESPONSABLES DE MOSAICISMO GENETICO... 218K€ Cerrado

NIMBL Nuclease Immune Mediated Brain and Lupus like conditions NI... 7M€ Cerrado

PCIN-2014-115 ESTUDIO DE LAS BASES MOLECULARES DE LA INTERFERNOPATIA TIPO... 150K€ Cerrado

IFNACTION A system view on the differential activities of human type I... 4M€ Cerrado

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Although the concept of grouping Mendelian disorders associated with an up-regulation of type I interferon (IFN) has not been previously recognised in the medical literature, my past and current work argues that this concept has scientific validity and clinical utility. I believe that such conditions, which include Aicardi-Goutières syndrome (AGS), spondyloenchondrodysplasia, and some cases of systemic lupus erythematosus (SLE), can usefully be considered to represent a novel set of inborn errors of immunity, and that the recognition of diseases as type I interferonopathies will have significance for the development of targeted therapies, as well as informing our understanding of viral and retroelement biology, and the pathogenesis of some forms of autoimmunity. This proposal will combine my expert phenotyping skills with revolutionary sequencing technologies, cutting edge systems for the interrogation of retroelements, and contemporary immunological assays. Deliberately focusing on human studies, I will identify new disease-related genes for AGS and lupus, and define currently unrecognised phenotypes arising from a dysregulation of type I IFN metabolism. I hypothesise that, to a currently undefined extent, SLE represents a heterogeneous collection of individually rare Mendelian subtypes, and suggest that the definition of new genetic subtypes of lupus will deliver a step change in our knowledge of disease pathogenesis through the delineation of pathways relevant to larger groups of patients. Since gene identification frequently represents a first step in understanding relevant cell biology, the work described herein has the potential to transform the clinical management of type I interferonopathies through the development of directed therapeutic approaches. Furthermore, I believe that our proposed experiments to study retroelement biology in the AGS-context are likely to reveal truly exciting insights into the activity and control of ‘junk’ DNA.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores